We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Omega-3 Fatty Acid Reduces Amyloid Buildup

By Biotechdaily staff writers
Posted on 08 Apr 2005
Researchers studying Alzheimer's disease have found that enriching the diet with the omega-3 fatty acid docosahexenoic acid (DHA) significantly reduced amyloid plaque buildup.

Investigators at the University of California, Los Angeles (USA) worked with a mouse model genetically engineered to develop symptoms of Alzheimer's disease. More...
Aged animals (17-19 months old) were placed in one of three groups, which until 22.5 months received food enriched with different levels of DHA: controls (0.09% DHA), low-DHA group (0%), or high-DHA group (0.6%).


When the animals reached 22.5 months of age, their brains were scanned for image analysis, and then an enzyme-linked immunosorbent assay (ELISA) was used to measure the amount of DHA in the detergent-insoluble extract of cortical homogenates. Results published in the March 23, 2005, issue of the Journal of Neuroscience revealed that DHA-enriched diets significantly reduced total amyloid protein by more than 70% when compared with low-DHA or control chow diets. Image analysis of brain sections with an antibody against amyloid protein (amino acids 1-13) showed that overall plaque burden was significantly reduced by 40.3%, with the largest reductions (40-50%) in the hippocampus and parietal cortex.

These results suggest that dietary DHA, such as fish oil, could be protective against beta-amyloid production, accumulation, and potential downstream toxicity. "The good news from this study is that we can buy the therapy at a supermarket or drug store,” said senior author Dr. Greg M. Cole, professor of neurosciences at the University of California, Los Angeles. "DHA has a tremendous safety profile--essentially no side effects--and clinical trial evidence supports giving DHA supplements to people at risk for cardiovascular disease.”



Related Links:
University of California, Los Angeles

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.